BOGOR, Indonesia, June 3, 2025 – PT Kalbe Farma Tbk (Kalbe) and GE HealthCare have opened Indonesia’s first facility for the production of CT (Computed Tomography) scanners. Located at PT Forsta Kalmedic Global (Forsta) in Bogor, the site marks a step toward establishing domestic manufacturing capacity for advanced medical imaging equipment. The initiative is intended to support the development of the country’s healthcare infrastructure by improving access to diagnostic technologies and reducing reliance on imported equipment.
The launch ceremony was attended by Indonesia’s director general pharmaceutical and medical device, Ministry of Health, Lucia Rizka Andalusia and deputy for licensing and inspection from the nuclear energy regulatory agency, Zainal Arifin, together with Elie Chaillot, president & CEO of GE HealthCare International and Irawati Setiady, president director of Kalbe.
The new facility is developed through a collaboration between GE HealthCare and Forsta, a subsidiary of Kalbe Farma. It supports Indonesia’s goal of improving access to medical imaging and advancing local production capabilities within Indonesia’s healthcare sector. “This facility will help us respond faster to local needs while maintaining the highest international standards of quality and safety,” said Elie Chaillot. “This production facility improves access to critical advanced diagnostic technology, creates high value jobs and supports the development of Indonesia’s health technology workforce.”
With a population of over 280 million spread across thousands of islands, Indonesia faces challenges in healthcare access. By establishing local production, Kalbe and GE HealthCare aim to reduce reliance on imports, cut delivery times, and make life-saving diagnostic tools more accessible to hospitals and clinics nationwide.
“The strategic partnership between Kalbe and GE HealthCare to supply CT scan machines locally exemplifies Kalbe’s commitment to government efforts focused on supporting national health resilience and local health industry self-sufficiency. We hope that by producing the CT Scan machines domestically will also enhance healthcare services and improving the quality of life for the Indonesian population,” stated Irawati.
CT scan is a commonly used medical imaging tool known for disease detection and diagnosis. “The establishment of CT scan machines local production is among the top ten health devices prioritized for local production. Therefore, establishing a domestic CT scan production facility is crucial for enhancing access to broader healthcare services. Forsta is proud to play a role in strengthening Indonesia’s ability to meet its own healthcare needs,” stated Yvone Astri Della Sijabat, director of Forsta.
The new production facility is expected to create skilled jobs and boost Indonesia’s health technology workforce. It will also support knowledge sharing in advanced medical manufacturing.
CT scanners rank among the top ten medical devices targeted by Indonesia for local manufacturing. The investment reinforces national efforts to expand medical technology capabilities and promote self-sufficiency in healthcare.
Source: GE HealthCare
About Kalbe
PT Kalbe Farma Tbk, founded in 1966 and based in Jakarta, Indonesia, is a pharmaceutical and healthcare company operating across four main segments: prescription drugs, consumer health products, nutritionals, and distribution. The company produces products including generic and branded medications, over-the-counter treatments, supplements, and functional beverages. Kalbe serves hospitals, clinics, pharmacies, and retailers, supported by a distribution network that covers over one million outlets in Indonesia. It has also expanded into several international markets, primarily in Southeast Asia and Africa. The company employs around 17,000 people. In 2024, Kalbe reported annual revenue of approximately IDR 32.6 trillion, or around USD 2.06 billion. Its business strategy emphasizes operational scale, regional reach, and diversification across healthcare-related product categories.
About GE HealthCare
GE Healthcare Technologies Inc., based in Chicago, IL, specializes in medical technology and digital healthcare solutions. It became a separate entity in January 2023 after separating from General Electric. With a history of over 100 years, the company focuses on four primary areas: Imaging, which includes systems like MRI, CT, and X-ray; Ultrasound for various medical uses; Patient Care Solutions, which covers monitoring systems, anesthesia, respiratory care, and diagnostic cardiology; and Pharmaceutical Diagnostics, producing contrast agents and radiopharmaceuticals for imaging. Serving healthcare providers worldwide, GE HealthCare aims to enhance hospital operations and clinical results. In 2023, the company reported approximately $20B in revenue. GE HealthCare employs over 50,000 people and operates in more than 160 countries, supporting hospitals and medical facilities with diagnostics, treatment, and patient care technologies.
About Forsta
PT Forsta Kalmedic Global (FORSTA), founded in 2019 and based in East Jakarta, Indonesia, is a medical device manufacturer under PT Enseval Medika Prima, part of the Kalbe Group. The company produces a range of medical and diagnostic equipment, including surgical sutures, dialyzers, mobile X-ray units, and CT scanners. Its manufacturing operations are located in the Pulogadung Industrial Estate and comply with both national and international standards. FORSTA’s primary objective is to support domestic healthcare capacity by localizing the production of medical technologies and reducing dependence on imported equipment. In partnership with GE HealthCare, FORSTA has recently launched Indonesia’s first CT scanner production facility in Bogor, which contributes to efforts to expand access to advanced diagnostic tools. Although its annual revenue is not publicly available, the company’s ongoing partnerships and production capabilities position it as a key contributor to Indonesia’s growing medical device sector.